Daly James M

CIK 00015607827 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001560782

Recent Transactions

50 trades

Award
CYTOKINETICS INC$CYTK
Common Stock
2026-01-15$63.44/sh+197→ 197 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-11-10$22.37/sh−30,000→ 4,041 total
Award
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-08-19+27,450→ 27,450 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-06-20+1,290→ 1,290 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-06-20+715→ 2,627 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2025-05-29+13,793→ 13,793 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-05-29+9,387→ 34,041 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-29−9,387→ 0 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-29+8,107→ 8,107 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$348.94/sh−770→ 1,912 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$111.06/sh+6,000→ 17,382 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-02-27−6,000→ 0 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$347.39/sh−14,302→ 2,682 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-02-27−9,470→ 0 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$65.06/sh+9,470→ 11,382 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$346.90/sh−398→ 16,984 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-06-25+1,105→ 1,105 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-06-25+714→ 1,912 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2024-05-29+15,959→ 15,959 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-29+6,652→ 24,654 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-29+9,387→ 9,387 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-29−6,652→ 0 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-02$248.45/sh−200→ 1,198 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-04-02−10,912→ 0 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-02$247.03/sh−43→ 1,398 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-02$246.30/sh−557→ 1,441 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-02$244.89/sh−2,991→ 1,998 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-02$244.19/sh−6,279→ 4,989 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-02$243.26/sh−842→ 11,268 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-02$105.08/sh+10,912→ 12,110 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$264.89/sh−351→ 1,972 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$263.31/sh−178→ 2,323 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$259.11/sh−200→ 3,301 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$257.30/sh−3,604→ 4,961 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$256.50/sh−7,401→ 8,565 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$265.49/sh−500→ 1,472 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$262.00/sh−800→ 2,501 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$258.28/sh−1,460→ 3,501 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$105.08/sh+1,577→ 22,775 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$100.45/sh+20,000→ 21,198 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$255.64/sh−6,809→ 15,966 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-04-01−1,577→ 10,912 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-04-01−20,000→ 0 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-04-01$266.91/sh−274→ 1,198 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2023-08-14$43.74/sh−10,000→ 20,503 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2023-08-11$43.71/sh−10,000→ 30,503 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-06-15+1,198→ 1,198 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-06-01+8,552→ 18,002 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-06-01+6,652→ 6,652 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2023-06-01+11,045→ 11,045 total

Companies

Recent Filings

Address

350 OYSTER POINT BLVD

SOUTH SAN FRANCISCO, CA, 94580

View on SEC.gov